Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-22

Clinical Trial Update: Ketoconazole Foam 2% for the Treatment of Versicolor [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ketoconazole foam 2% for tinea versicolor has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole foam 2% (ketoconazole)

Snippet

Sponsor: Boni Elewski, MD | Conditions: Tinea Versicolor | Phase 4 | Status: COMPLETED | Results posted: 2012-08-22